Filing Details
- Accession Number:
- 0001209191-15-078176
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-03 18:01:53
- Reporting Period:
- 2015-10-30
- Filing Date:
- 2015-11-03
- Accepted Time:
- 2015-11-03 18:01:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-10-30 | 1,600 | $123.34 | 248,448 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-30 | 1,400 | $124.33 | 247,048 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-30 | 4,800 | $125.35 | 242,248 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-30 | 8,125 | $126.31 | 234,123 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-30 | 200 | $126.86 | 233,923 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $123.34 (range $122.82 to $123.79).
- Open market sales reported on this line occurred at a weighted average price of $124.33 (range $123.83 to $124.74).
- Open market sales reported on this line occurred at a weighted average price of $125.35 (range $124.85 to $125.84).
- Open market sales reported on this line occurred at a weighted average price of $126.31 (range $125.85 to $126.81).
- Open market sales reported on this line occurred at a weighted average price of $126.86 (range $126.85 to $126.87).
Billionaire Hedge Funds
